AI assistant
Sending…
Ocugen, Inc. — Proxy Solicitation & Information Statement 2022
May 20, 2022
32915_rns_2022-05-20_b20588d9-59b0-41da-8955-2fa91316d875.zip
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
DEFA14A 1 tm2215277d3_defa14a.htm DEFA14A
Field: Rule-Page
Field: /Rule-Page
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
| x | Filed by the Registrant |
|---|---|
| ¨ | Filed by a Party other than the Registrant |
| Check the appropriate box: | |
| ¨ | Preliminary Proxy Statement |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ¨ | Definitive Proxy Statement |
| x | Definitive Additional Materials |
| ¨ | Soliciting Material under §240.14a-12 |
OCUGEN, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
| Payment of Filing Fee (Check all boxes that apply): | |
|---|---|
| x | No fee required |
| ¨ | Fee paid previously with preliminary materials |
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
Field: Page; Sequence: 2; Options: Last
Field: /Page
More from Ocugen, Inc.
Board/Management Information
2026
Jun 3
Board/Management Information
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Capital/Financing Update
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Capital/Financing Update
2026
Mar 20
Annual Report
2026
Mar 4